PHARMACIA ITALIA S.P.A.
Patent Owner
Stats
- 6 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Feb 04, 2014 most recent publication
Details
- 6 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,179 Total Citation Count
- Dec 09, 1982 Earliest Filing
- 125 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
7259244 Human homologue of the DBF4/ASK1 protein, nucleic acids, and methods related to the sameJun 15, 01Aug 21, 07[A61K]
7030089 Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathioneApr 19, 01Apr 18, 06[A61K]
6482920 Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agentsJan 22, 99Nov 19, 02[C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
8642580 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and platinum derivativesExpiredJun 20, 01Feb 04, 14[A61K, A01N, A61P]
2011/0166,077 COMBINED THERAPY AGAINST TUMORS COMPRISING SUBSTITUTED ACRYLOYL DISTAMYCIN DERIVATIVES AND RADIOTHERAPYAbandonedOct 01, 04Jul 07, 11[A61K]
7642229 Pharmaceutical composition and a product which includes a substituted acryloyl distamycin derivative, an antimicrotubule agent and/or an antimetaboliteExpiredJun 20, 01Jan 05, 10[A61K, C07K]
2007/0142,414 N-substituted pyrrolopyridinones active as kinase inhibitorsAbandonedDec 16, 05Jun 21, 07[A61K, C07D]
2006/0183,168 Method for optimizing therapeutic efficacy of nemorubicinAbandonedOct 08, 03Aug 17, 06[A61K, G01N]
2006/0084,612 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitorsAbandonedDec 18, 02Apr 20, 06[A61K]
2006/0074,243 Hydroxamic acid and amide compounds and their use as protease inhibitorsAbandonedNov 10, 05Apr 06, 06[C07D]
2006/0046,993 Crystalline polymorphic form of irinotecan hydrochlorideAbandonedSep 01, 04Mar 02, 06[A61K, C07D]
6974828 Propanoic acid derivatives as intergrin receptor antagonistsExpiredApr 19, 01Dec 13, 05[A61K, C07D]
2005/0176,796 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agentsAbandonedApr 18, 05Aug 11, 05[A61K]
2005/0143,927 Method for estimating or predicting the anti-tumor activity of a compound and for estimating or predicting the tumor growth in mammalsAbandonedSep 15, 04Jun 30, 05[G06F]
2005/0107,543 Fluoro linkers and their use as linkers for enzyme-activated drug conjugatesAbandonedDec 01, 04May 19, 05[C07F, C08G]
2005/0059,156 Method for detecting contaminants in pharmaceutical productsAbandonedAug 05, 04Mar 17, 05[G01N, B01D]
2005/0038,112 Simplified sarcondictyn derivatives as anti-tumor agentsAbandonedOct 07, 04Feb 17, 05[A61K, C07C]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.